Perspective Therapeutics (CATX) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -137.42%
Dec 31, 2025 -49.00%
Sep 30, 2025 -47.64%
Jun 30, 2025 -85.08%
Mar 31, 2025 -85.99%
Dec 31, 2024 -55.50%
Sep 30, 2024 -71.14%
Jun 30, 2024 -66.17%
Mar 31, 2024 -40.71%
Dec 31, 2023 1.22%
Sep 30, 2023 -110.06%
Jun 30, 2023 -127.91%
Mar 31, 2023 -147.48%
Dec 31, 2022 -139.63%
Sep 30, 2022 -127.84%
Jun 30, 2022 -118.93%
Mar 31, 2022 -109.65%
Dec 31, 2021 -97.22%
Sep 30, 2021 -88.62%
Jun 30, 2021 -165.12%
Mar 31, 2021 -143.07%
Dec 31, 2020 -19.08%
Sep 30, 2020 35.58%
Jun 30, 2020 35.64%
Mar 31, 2020 38.63%
Dec 31, 2019 35.67%
Sep 30, 2019 30.64%
Jun 30, 2019 24.52%
Mar 31, 2019 18.03%
Dec 31, 2018 14.52%
Sep 30, 2018 -79.56%
Jun 30, 2018 38.31%
Mar 31, 2018 -61.22%
Dec 31, 2017 -61.93%
Jun 30, 2017 20.24%
Mar 31, 2017 24.00%
Dec 31, 2016 -39.36%
Sep 30, 2016 -37.40%
Jun 30, 2016 -62.25%
Mar 31, 2016 -46.59%
Dec 31, 2015 -41.56%
Sep 30, 2015 31.90%
Jun 30, 2015 -76.07%
Mar 31, 2015 24.71%
Dec 31, 2014 27.00%
Jun 30, 2014 -103.05%
Mar 31, 2014 -89.63%
Dec 31, 2013 -16.80%
Sep 30, 2013 -72.77%